Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fredrik Persson
Institution:
Sahlgrenska University Hospital
Observed institution:
Sahlgrenska University Hospital
ORCID:
0000-0002-5374-4770
Observed ORCID:
0000-0002-5374-4770
OpenAlex ID:
A5103787468
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis
2017
·
Jenny Nyqvist
, Fredrik Persson
, et al.
·
Case Reports in Oncology
·
19
PDF
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
·
Clinical Cancer Research
·
8
PDF
Z-score-based posttest risk as an alternative risk metric to positive predictive value following positive noninvasive prenatal screening
2024
·
Emily Gaudet
, Fredrik Persson
, et al.
·
American Journal of Obstetrics and Gynecology
·
6
PDF
Supplementary Table 2 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
Data from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
Supplementary Table 4 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
Supplementary Figure 1 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
Supplementary Figure 3 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
PDF
Supplementary Figure 6 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
PDF
Supplementary Figure 2 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
PDF
Supplementary Figure 5 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
PDF
Supplementary Table 1 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
Supplementary Figure 4 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
PDF
Supplementary Table 3 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
2025
·
Bianca Tesi
, Anna Robelius
, et al.
P506: Clinical Validation of the Nordic Guidelines for Germline Testing in Myeloid Neoplasms: Results From a Multi-center Prospective Cohort Study
2023
·
Bianca Tesi
, Anna Eriksson
, et al.
·
HemaSphere
Show more works
View as search
Works count:
15
Citation count:
33
H-index:
3
I10-index:
1
Year
Topic
Type